bluebird bio Inc. (BLUE) News, Price and Chart

Mon May 17th, 2021

- 19:54
  Analysisbluebird bio's Current Price Levels Offer An Attractive Risk-Return PlaySeeking Alpha

Thu May 6th, 2021

- 16:22
  Analysisbluebird (BLUE) Q1 Loss Wider Than Expected, Revenues BeatZacks

Mon April 26th, 2021

- 13:45
  Press ReleasesInsights on the Advanced Therapy Medicinal Products Global Market to 2027 - Featuring Bluebird Bio, Celgene and Gilead Lifesciences Among OthersPR Newswire

Thu April 22nd, 2021

- 17:42
  AnalysisCryoport: Once In A Lifetime OpportunitySeeking Alpha

Wed April 14th, 2021

- 10:30
  AnalysisIs bluebird bio a Bad News Buy?The Motley Fool

Mon April 12th, 2021

- 19:48
  Press ReleasesClass ActionsBLUE INVESTOR FILING DEADLINE TOMORROW : Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.PR Newswire

Sun April 11th, 2021

- 10:22
  Press ReleasesClass ActionsTUESDAY DEADLINE ALERT: ROSEN, A TOP RANKED FIRM, Encourages bluebird bio, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUEPR Newswire

Tue April 6th, 2021

- 14:35
  AnalysisCRISPR Therapeutics's Leading Thalassemia And Sickle Cell Disease Investigational TherapySeeking Alpha

Fri April 2nd, 2021

- 12:49
  AnalysisAre bluebird bio's Troubles Behind It?The Motley Fool

Mon March 29th, 2021

Wed March 24th, 2021

- 16:18
  AnalysisOrchard Therapeutics: Curative Medicines For Immune-Related DiseasesSeeking Alpha
- 07:39
  Press ReleasesClass ActionsSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUEPR Newswire

Sat March 20th, 2021

- 22:20
  Press ReleasesClass ActionsROSEN, A LEADING LAW FIRM, Encourages bluebird bio, Inc. Investors with Large Losses to Secure Counsel Before Important April 13 Deadline in Securities Class Action - BLUEPR Newswire
- 13:52
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsFDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And EarningsBenzinga

Thu March 18th, 2021

- 13:47
  Press ReleasesClass ActionsBLUE INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.PR Newswire

Tue March 16th, 2021

- 13:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisVertex: 45% Upside RemainsSeeking Alpha

Sun March 14th, 2021

- 16:18
  Analysisbluebird bio's Awkward SilenceSeeking Alpha

Wed March 10th, 2021

Thu March 4th, 2021

- 21:36
  Press ReleasesClass ActionsINVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPR Newswire

Tue March 2nd, 2021

- 04:54
  Press ReleasesROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUEPR Newswire

Wed February 24th, 2021

- 17:53
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Analysisbluebird (BLUE) Q4 Loss Narrower than Expected, Sales MissZacks
- 11:56
  AnalysisIs There Any Hope for bluebird bio Stock?The Motley Fool

Tue February 23rd, 2021

- 20:53
  AnalysisCRISPR Therapeutics: Roadblock AheadSeeking Alpha

Fri February 19th, 2021

- 05:05
  Press ReleasesClass ActionsSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUEPR Newswire

Thu February 18th, 2021

Wed February 17th, 2021

- 16:03
  Analysisbluebird (BLUE) Down on Suspension of Sickle Cell Disease StudiesZacks
- 07:43
  AnalysisCancer And Gene TherapySeeking Alpha

Tue February 16th, 2021

- 18:13
  AnalysisWhy bluebird bio Stock Is Plunging TodayThe Motley Fool

Fri February 12th, 2021

- 22:53
  Press ReleasesClass ActionsPomerantz Law Firm Announces the Filing of a Class Action against bluebird bio, Inc. and Certain Officers - BLUEPR Newswire

Tue February 9th, 2021

- 17:30
  EarningsAnalysisBluebird Bio (BLUE) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks

Tue January 12th, 2021

- 18:19
  Analysisbluebird (BLUE) to Spin Off Oncology Unit Into Separate EntityZacks

Mon January 11th, 2021

- 16:51
  Analysisbluebird bio to Spin Off Its Oncology BusinessThe Motley Fool + 1 more